유럽의 진단용 질량분석과 크로마토그래피 시장 : 제품 유형별, 용도 태국별, 국가별 - 분석과 예측(2024-2033년)

Introduction to Europe Mass Spectrometry and Chromatography in Diagnostics Market

The Europe mass spectrometry and chromatography in diagnostics market was valued at $224.0 million in 2024 and is expected to reach $503.3 million by 2033, growing at a CAGR of 9.41% between 2024 and 2033. The analytical and life sciences instrumentation sector in Europe relies heavily on the mass spectrometry (MS) and chromatography markets. These technologies propel advancements in pharmaceuticals, environmental monitoring, diagnostics, and food safety, among other fields, by offering sophisticated techniques for the separation, identification, and quantification of chemical and biological substances. Instead of being used separately, mass spectrometry and chromatography are usually incorporated into workflows in diagnostics. For instance, liquid chromatography-mass spectrometry is perfect for complex sample analysis because it combines the mass analysis capability of mass spectrometry with the separation power of liquid chromatography. In clinical settings, where high-throughput analysis of patient samples is crucial for offering thorough insights that guide diagnosis and treatment, this hybrid approach is especially beneficial. Important diagnostic uses for these technologies in Europe include vitamin profiling, hormone profiling, and other tests that require precise separation and analysis of components.

Market Introduction

The growing complexity of patient samples and the growing need for precision diagnostics are driving the rapid evolution of the Europe mass spectrometry and chromatography in diagnostics market. Clinical diagnostics, personalized medicine, and the search for biomarkers all depend on mass spectrometry (MS) and chromatography technologies because they offer advanced techniques for the separation, identification, and quantification of chemical and biological materials.

Because they provide high-throughput, precise, and dependable analysis for complicated clinical samples, hybrid systems like liquid chromatography-mass spectrometry (LC-MS) have become essential to contemporary diagnostic workflows. These technologies are especially useful for analyzing vitamins, metabolites, hormones, and biomarkers, which allows for early disease detection and individualized treatment plans.

Improvements in metabolomics and proteomics are also driving the market since they are facilitating better disease monitoring, screening, and treatment planning. The need for high-performance diagnostic tools is being further stimulated by growing research into biomarker identification and targeted therapies.

Furthermore, the use of mass spectrometry and chromatography in diagnostics is expanding throughout Europe due to regulatory support, enhanced healthcare infrastructure, and the incorporation of AI-driven analytics. The use of these technologies is anticipated to spread across a variety of clinical applications as they become more widely available, propelling the European diagnostics market's ongoing expansion.

Market Segmentation:

Segmentation 1: by Product Type

• Sample Preparation
• Mass Spectrometry and Chromatography

Segmentation 2: by Application Type

• Therapeutic Drug Monitoring
• Vitamins
• Hormones
• Methylmalonic Acid
• Immunosuppressants
• Others

Segmentation 3: by Country

• Germany
• U.K.
• Spain
• Italy
• France
• Rest-of-Europe

How can this report add value to an organization?

Product/Innovation Strategy: The Europe mass spectrometry and chromatography in diagnostics market has been segmented based on various categories, such as by product type, application type, and country. This can help readers get a clear overview of which segments account for the largest share and which ones are well-positioned to grow in the coming years.

Competitive Strategy: The Europe mass spectrometry and chromatography market consists of various public and few private companies. Key players in the Europe mass spectrometry and chromatography in diagnostics market analyzed and profiled in the study involve established players that offer various kinds of products.

Key Market Players and Competition Synopsis

The companies profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.

Some prominent names established in this market are:

• Tecan Group Ltd.
• Merck KGaA
• Chromsystems Instruments & Chemicals GmbH
• RECIPE Chemicals + Instruments GmbH
• SENTINEL CH. SpA

Table of Contents

Executive Summary

Scope and Definition

1 Mass Spectrometry and Chromatography in Diagnostics Market: Industry Outlook

• 1.1 Market Overview
• 1.2 Key Trends
  • 1.2.1 Shift toward Utilization of Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) as Standard Technique in Diagnostics
  • 1.2.2 Utilization of Automated Sample Preparation Technologies
• 1.3 Opportunity Assessment of Key Trends
• 1.4 Product Benchmarking
• 1.5 Regulatory Landscape
  • 1.5.1 Regulatory Framework in Europe
    • 1.5.1.1 Recommendations for Diagnostic Approval

2 Region

• 2.1 Regional Summary
• 2.2 Drivers and Restraints
• 2.3 Europe
  • 2.3.1 Regional Overview
  • 2.3.2 Driving Factors for Market Growth
  • 2.3.3 Factors Challenging the Market
  • 2.3.4 By Product Type
  • 2.3.5 By Application Type
  • 2.3.6 U.K.
    • 2.3.6.1 By Product Type
    • 2.3.6.2 By Application Type
  • 2.3.7 Germany
    • 2.3.7.1 By Product Type
    • 2.3.7.2 By Application Type
  • 2.3.8 France
    • 2.3.8.1 By Product Type
    • 2.3.8.2 By Application Type
  • 2.3.9 Italy
    • 2.3.9.1 By Product Type
    • 2.3.9.2 By Application Type
  • 2.3.10 Spain
    • 2.3.10.1 By Product Type
    • 2.3.10.2 By Application Type
  • 2.3.11 Rest-of-Europe
    • 2.3.11.1 By Product Type
    • 2.3.11.2 By Application Type

3 Mass Spectrometry and Chromatography in Diagnostics Market: Competitive Benchmarking and Company Profile

• 3.1 Competitive Landscape
  • 3.1.1 Partnerships, Alliances, and Business Expansions
  • 3.1.2 New Offerings
  • 3.1.3 Mergers and Acquisitions
  • 3.1.4 Regulatory Approvals
• 3.2 Key Strategies and Development
• 3.3 Company Competition Matrix
• 3.4 Company Share Analysis
• 3.5 Company Profiles
  • 3.5.1 Tecan Group Ltd.
    • 3.5.1.1 Overview
    • 3.5.1.2 Top Products
    • 3.5.1.3 Top Competitors
    • 3.5.1.4 Top Customers
    • 3.5.1.5 Key Personnel
    • 3.5.1.6 Analyst View
  • 3.5.2 Merck KGaA
    • 3.5.2.1 Overview
    • 3.5.2.2 Top Products
    • 3.5.2.3 Top Competitors
    • 3.5.2.4 Top Customers
    • 3.5.2.5 Key Personnel
    • 3.5.2.6 Analyst View
  • 3.5.3 Chromsystems Instruments & Chemicals GmbH.
    • 3.5.3.1 Overview
    • 3.5.3.2 Top Products
    • 3.5.3.3 Top Competitors
    • 3.5.3.4 Top Customers
    • 3.5.3.5 Key Personnel
    • 3.5.3.6 Analyst View
  • 3.5.4 RECIPE Chemicals + Instruments GmbH
    • 3.5.4.1 Overview
    • 3.5.4.2 Top Products
    • 3.5.4.3 Top Competitors
    • 3.5.4.4 Top Customers
    • 3.5.4.5 Key Personnel
    • 3.5.4.6 Analyst View
  • 3.5.5 SENTINEL CH. SpA
    • 3.5.5.1 Overview
    • 3.5.5.2 Top Products
    • 3.5.5.3 Top Competitors
    • 3.5.5.4 Top Customers
    • 3.5.5.5 Key Personnel
    • 3.5.5.6 Analyst View

4 Research Methodology

• 4.1 Data Sources
  • 4.1.1 Primary Data Sources
  • 4.1.2 Secondary Data Sources
  • 4.1.3 Data Triangulation